NGN Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4

- Investments
-
57
- Portfolio
-
4
- Exits
-
30

NGN Capital General Information
Description
Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut. The firm prefers to invest in early-stage and later-stage companies operating in healthcare, life sciences, oncology, and TMT sectors based in the United States and Europe.
Contact Information
Website
www.ngncapital.com
Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 60 Long Ridge Road
- Suite 402
- Stamford, CT 06902
- United States
+1 (212) 000-0000
NGN Capital Investments (57)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
OptiScan | 20-Mar-2019 | Later Stage VC | 0000 | Monitoring Equipment | Bankruptcy: Admin/Reorg | 0000000 0000000000 |
0000000 0000000000 | 05-Jul-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
00000000000 | 01-Feb-2017 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | |
0000000 0000000000 | 07-Jan-2016 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
000000 0000000 | 23-Jul-2014 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | |
0000000 0000000000 | 12-Mar-2014 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
0000 0000000 00000 | 05-Mar-2014 | 00000 00000 | 00.00 | Business/Productivity Software | Out of Business | |
000000000 | 05-Mar-2013 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 00000 000000 00.0 |
Cerapedics | 12-Dec-2012 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | 0000000 0000000000 |
PIN Pharma | 01-Jan-2012 | Early Stage VC | 00.000 | Biotechnology | Generating Revenue | 0000 0000000 |
NGN Capital Exits (30)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Cardiovalve | 25-Jan-2022 | Merger/Acquisition | 00000 |
0000 0000000 00000 | 17-Dec-2021 | 000 00 00000000 | |
000 000000 | 01-Apr-2021 | 000000000 00000000 | |
00000000 | 02-Jun-2020 | 0000000000: 000000 | |
000000 0000000 | 06-Mar-2020 | 000 | 00000 |
0000000 0000000000 | 01-Aug-2018 | 000000000000000000 | 00000 |
0000000 000000 | 23-Jan-2017 | 000000000000000000 | 00000 |
000000000 | 01-Oct-2016 | 000000000000000000 | 00.000 |
SpineView | 01-Oct-2016 | Out of Business | |
TME Pharma | 30-Sep-2016 | IPO |
NGN Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
NGN Capital Investments by Industry, Year, and Region
NGN Capital Team (20)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Alexander Cuomo | Chief Financial Officer | Stamford, CT | |||
Kenneth Abramowitz | Co-Founder & Managing General Partner | 00 | 0 | 0 | Stamford, CT |
Peter Johann Ph.D | Managing General Partner | 0 | 0 | 0 | Heidelberg, Germany |
Kenneth Gorelick MD | Venture Partner | Stamford, CT | |||
William Gedale JD | Senior Advisor & Co-Founder | 0 | Stamford, CT |
NGN Capital Co-Investors (6)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Biobrit | 1 | 0 | 0 |
![]() |
![]() |
Crown Venture Fund | 0 | 0 | 0 |
![]() |
![]() |
Revelation Partners | 0 | 0 | 0 |
![]() |
![]() |
Wexford Capital | 0 | 0 | 0 |
![]() |
![]() |
Xeraya Capital | 0 | 0 | 0 |
![]() |
![]() |